The metabolism and pharmacokinetics of 14C-cetirizine in humans.
This study investigated the metabolism and pharmacokinetics of cetirizine, a new H1-receptor antagonist. Single oral doses of 14C-cetirizine dihydrochloride (10 mg) in aqueous solution were administered to six healthy male volunteers. The drug was rapidly absorbed: The peak mean concentration of radioactivity (359 ng-equivalents/mL) and of unchanged drug (341 ng/mL) were achieved within one hour. Mean concentrations of cetirizine declined biexponentially and had a mean elimination half-life of 7.4 hours. The drug was excreted quite rapidly, with 60% of the dose recovered in the 24-hour urine. An additional 10% was excreted in urine over the next four days. Approximately 10% of the dose was excreted in feces over the five-day study period. The dose was excreted mainly as the unchanged drug. Examination of the radioactive compounds present in the plasma, and excreted in the urine and feces indicate that there is little metabolism of cetirizine. One minor metabolite, formed by oxidative O-dealkylation of the cetirizine side chain, was detected in plasma and feces.
D000328:Adult; D002250:Carbon Radioisotopes; D017332:Cetirizine; D002855:Chromatography, Thin Layer; D005243:Feces / Q000032:analysis; D006634:Histamine H1 Antagonists / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D006801:Humans; D006919:Hydroxyzine / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics; D008297:Male
D002250:Carbon Radioisotopes; D006634:Histamine H1 Antagonists; D006919:Hydroxyzine; D017332:Cetirizine